Today: 29 April 2026
Centene (CNC) Slides on ACA-Subsidy Uncertainty as Wellcare Expands in Texas and Ambetter Adds South Carolina Plans — Nov. 10, 2025
10 November 2025
3 mins read

Centene (CNC) Slides on ACA-Subsidy Uncertainty as Wellcare Expands in Texas and Ambetter Adds South Carolina Plans — Nov. 10, 2025

  • Shares of Centene (NYSE: CNC) fell today alongside other managed-care names after President Trump urged redirecting Affordable Care Act (ACA) subsidies away from insurers; Reuters cited ~7% premarket pressure for CNC.
  • Centene issued two expansion press releases this morning:
    • Wellcare will offer Medicare Advantage and Part D plans in 205 Texas counties for 2026, with an enhanced integrated D‑SNP model in Dallas and Hidalgo counties.
    • Ambetter from Absolute Total Care will offer statewide 2026 Marketplace plans in South Carolina, with open enrollment now underway.

Market snapshot

As of 14:48 UTC on Nov. 10, CNC traded at $33.91 (intraday range $33.64–$36.09).

Why CNC is under pressure today

In posts over the weekend, President Donald Trump called for redirecting “hundreds of billions” in ACA subsidy funds directly to consumers, rather than to insurers. By early Monday, managed-care stocks with ACA exposure, including Centene, were lower in premarket trading. Reuters notes the comments land amid a 40‑day federal government shutdown and renewed debate over enhanced ACA subsidies set to expire Dec. 31, a program that has helped double ACA enrollment to ~24 million since 2021. Reuters


Company announcements (Nov. 10, 2025)

1) Wellcare broadens Texas Medicare footprint for 2026

Time: 9:00 a.m. ET
What’s new:Wellcare (Centene’s Medicare brand) said it will offer MA and Part D plans in 205 Texas counties in 2026, including major metros (Austin, Dallas, El Paso, Houston, San Antonio). The release highlights a first-phase rollout of an enhanced integrated D‑SNP model (administering both Medicare and Medicaid benefits) in Dallas and Hidalgo counties, as the industry transitions from MMPs to integrated D‑SNPs on Jan. 1, 2026. Wellcare says its 2026 MA/PDP lineup spans 32 states and 1,850+ counties, reaching 51M+ eligible beneficiaries, with features such as the Wellcare Spendables® card and $0 PCP copays on all plans. Medicare AEP runs Oct. 15–Dec. 7, 2025 (coverage effective Jan. 1, 2026).

2) Ambetter launches 2026 Marketplace plans statewide in South Carolina

Time: 8:01 a.m. ET
What’s new:Ambetter from Absolute Total Care will offer ACA Marketplace plans statewide in South Carolina for plan year 2026. Marketplace open enrollment runs Nov. 1, 2025–Jan. 15, 2026; enroll by Dec. 15 for Jan. 1 coverage. The release spotlights Virtual 24/7 Care, My Health Pays® rewards up to $500 for qualifying activities, and Ambetter Health Solutions (off‑exchange products compatible with ICHRAs) available in select states, including South Carolina.

Today’s Centene news timeline (ET)
8:01 a.m. – Ambetter SC statewide 2026 plans announced.
9:00 a.m. – Wellcare Texas 2026 MA/PDP expansion announced.
(Source: Centene press room.)


Context: Where fundamentals stand after Q3

Late last month, Centene raised its 2025 adjusted EPS outlook to at least $2.00 and said it expects to grow adjusted EPS in 2026, after posting Q3 adjusted EPS of $0.50 on revenue of ~$49.7B (+18% Y/Y). The quarter also included a $6.7B non‑cash goodwill impairment, producing a GAAP loss but tied primarily to anticipated policy changes beyond 2025. Shares rallied on the beat and outlook at the time.


What it means

  • Policy overhang vs. growth initiatives: Today’s selloff underscores how ACA‑subsidy policy risk can overshadow near‑term footprint expansion (Wellcare MA/PDP; Ambetter Marketplace) and recent operating progress in Medicaid. Centene remains among the most ACA‑exposed national payers, making it more sensitive to headlines around enhanced subsidy renewal and risk‑adjustment dynamics.
  • Medicare and D‑SNP strategy: The Texas D‑SNP integration and broad MA/PDP coverage reflect Centene’s push to better coordinate care for dual‑eligible members, an area that can improve retention and quality metrics but requires careful execution and state‑federal alignment.

Key dates consumers should know

  • Medicare AEP (for 2026 coverage):Oct. 15–Dec. 7, 2025 (enroll by Dec. 7 for Jan. 1, 2026 effective date). Texas beneficiaries can compare Wellcare options during this window.
  • ACA Marketplace open enrollment (for 2026 coverage):Nov. 1, 2025–Jan. 15, 2026 (enroll by Dec. 15 for Jan. 1, 2026 start). South Carolina residents can view Ambetter plans now.

Bottom line for investors

Today (Nov. 10, 2025) brought two expansion releases from Centene plus a macro-policy shock that weighed on the stock. The debate over enhanced ACA subsidies remains the single largest external swing factor for ACA‑centric insurers heading into 2026 rate‑setting and enrollment — even as Centene signals EPS growth ambitions for 2026 and invests in Medicare/D‑SNP integration. Keep an eye on Congress’s path on subsidy renewal and Centene’s February guidance update for clearer visibility into next year’s earnings trajectory.


This article is for informational purposes only and is not investment advice. All plan features and eligibility vary by state and product; consult official plan documents for details.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Is Strategy (MSTR) Undervalued After 56.6% One-Year Share Price Drop?
    April 29, 2026, 12:04 PM EDT. Strategy (MSTR) shares have fallen 56.6% over the past year, raising questions about their value amid volatile market conditions. Despite this drop, the stock gained 168.6% over five years and recently rose 31.5% in the last month. A two-stage discounted cash flow (DCF) analysis suggests the stock is undervalued by approximately 71%, implying a potential buying opportunity. The DCF model forecasts significant free cash flow growth, reaching $16.3 billion by 2035. However, the latest twelve-month free cash flow shows a loss of $87.7 million. The article compares valuation metrics like price-to-book ratio to provide broader context. Investors might consider these insights as they evaluate Strategy's current market position and future prospects.

Latest article

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

29 April 2026
Cognizant forecast second-quarter revenue below analyst estimates and announced Project Leap, a cost-cutting program focused on workforce reductions. Shares fell $1.67 to $53.45. The company reported first-quarter revenue of $5.41 billion, up 5.8%, and agreed to acquire AI infrastructure firm Astreya for about $600 million.
ON Semiconductor Stock Jumps as Geely and NIO Deals Put 900V EV Chips in Focus

ON Semiconductor Stock Jumps as Geely and NIO Deals Put 900V EV Chips in Focus

29 April 2026
ON Semiconductor shares jumped 8% Wednesday after announcing expanded silicon carbide chip deals with Geely Auto Group and NIO Inc., both focused on 900-volt electric vehicle platforms. The company’s market value reached about $41.2 billion ahead of first-quarter results due May 4. Investors are watching whether new auto-chip wins can offset uneven demand.
Stocks to Watch Today (Nov. 10, 2025): Nvidia Rebounds; Pfizer Clinches Metsera; Novo Nordisk Rises; Rumble Soars on AI Deal; Tyson Foods Guides Higher
Previous Story

Stocks to Watch Today (Nov. 10, 2025): Nvidia Rebounds; Pfizer Clinches Metsera; Novo Nordisk Rises; Rumble Soars on AI Deal; Tyson Foods Guides Higher

SCHD Today (Nov. 10, 2025): Price, Yield & Flows—How Schwab’s Dividend ETF Stacks Up vs. JEPI, DIVO & DIV for Retirement Income
Next Story

SCHD Today (Nov. 10, 2025): Price, Yield & Flows—How Schwab’s Dividend ETF Stacks Up vs. JEPI, DIVO & DIV for Retirement Income

Go toTop